Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Uniuse en maio 2012
5 Fotos ou vídeos Fotos e vídeos

Chíos

You blocked @AblynxABLX

Estás seguro de que queres ver estes chíos? Ver os chíos non desbloqueará a @AblynxABLX

  1. rechouchiou
    26 xul

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 rechouchíos 4 gústames
  2. rechouchiou
    20 xul

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 rechouchíos 7 gústames
  3. 20 xul

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 resposta 9 rechouchíos 14 gústames
  4. 27 xuñ

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 rechouchíos 16 gústames
  5. 26 xuñ

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 rechouchíos 6 gústames
  6. 29 mai

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 rechouchíos 9 gústames
  7. 22 mai

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 rechouchíos 12 gústames
  8. 18 mai

    Meet our experts and recruiters (booth 99) @

    2 gústames
  9. 11 mai

    Ablynx zit op schema via

    4 rechouchíos 6 gústames
  10. 11 mai

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 rechouchíos 4 gústames
  11. 10 mai

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 rechouchíos 7 gústames
  12. 2 mai

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 rechouchíos 6 gústames
  13. 7 abr

    Annual Report 2016 is available online - view via

    1 rechouchío 4 gústames
  14. 7 abr

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 rechouchío 4 gústames
  15. rechouchiou
    6 mar

    Compelling data for developed psoriasis nanobody in collaboration

    3 rechouchíos 2 gústames
  16. rechouchiou
    28 feb

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 respostas 51 rechouchíos 103 gústames
  17. rechouchiou
    24 feb

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 rechouchío 1 gústame
  18. 23 feb

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 rechouchíos 3 gústames
  19. 9 feb

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 rechouchíos 2 gústames
  20. 6 feb

    Ablynx files caplacizumab for ultra rare blood disorder
    6 rechouchíos 9 gústames

@AblynxABLX hasn't Tweeted yet.

Parece que a carga tarda un chisco

É posible que o Twitter estea por riba da súa capacidade ou teña un impo momentáneo. Téntao de novo ou visita o Estado do Twitter para obter máis información.

    Tamén che pode gustar

    ·